Investing
Top 10 Pre-Market Analyst Calls (ABT, MO, AMGN, CRME, FNM, FRE, IBN, PNRA, SNDK, ZMH)
Published:
These are the top analyst calls we are focusing on early this Thursday morning in pre-market trading:
- Abbott Laboratories (NYSE: ABT) Raised To Outperform at Wachovia.
- Altria (NYSE: MO) started as Buy at UBS.
- Amgen (NASDAQ: AMGN) downgraded to Market Perform at Wachovia.
- Cardiome Pharma (NASDAQ: CRME) started At Outperform at Wachovia.
- Fannie Mae (NYSE: FNM) raised to Outperform at KBW.
- Freddie Mac (NYSE: FRE) raised to Outperform at KBW.
- ICICI Bank (NYSE: IBN) downgraded to Underperform at Jefferies.
- Panera Bread (NASDAQ: PNRA) downgraded to Neutral at JP Morgan.
- SanDisk NASDAQ: SNDK) downgraded to Neutral at JP Morgan.
- Zimmer Holdings (NYSE: ZMH) raised to Overweight at Lehman Brothers.
Jon C. Ogg
March 20, 2008
The #1 Thing to Do Before You Claim Social Security (Sponsor)
Choosing the right (or wrong) time to claim Social Security can dramatically change your retirement. So, before making one of the biggest decisions of your financial life, it’s a smart idea to get an extra set of eyes on your complete financial situation.
A financial advisor can help you decide the right Social Security option for you and your family. Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to three financial advisors who serve your area, and you can interview your advisor matches at no cost to decide which one is right for you.
Click here to match with up to 3 financial pros who would be excited to help you optimize your Social Security outcomes.
Have questions about retirement or personal finance? Email us at [email protected]!
By emailing your questions to 24/7 Wall St., you agree to have them published anonymously on a673b.bigscoots-temp.com.
By submitting your story, you understand and agree that we may use your story, or versions of it, in all media and platforms, including via third parties.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
